Davidson Kempner Capital Management Lp

Q4 2023 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Eric Sacks - Chief Financial Officer
Location
New York
Holdings as of
31 Dec 2023
Value $
$858M
Num holdings
1
Filing time
15 May 2024, 15:36:59
Form type
13F-HR/A-2 - New Holdings
Description
Top holdings included PXD. Request for Confidential Treatment (14 Feb 2024): Confidential Treatment Expired on 14 Nov 2024.
Previous filing
Q3 2023 - 14 Nov 2023
Next filing
Q1 2024 - 15 May 2024
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Feb 2024 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Nov 2024.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Eric Sacks Chief Financial Officer New York, New York 13 May 2024